1. P929: IXAZOMIB AND DARATUMUMAB WITHOUT DEXAMETHASONE (I-DARA) IN ELDERLY FRAIL RELAPSING MYELOMA (RRMM) PATIENTS: RESULTS OF THE PHASE 2 STUDY IFM 2018-02 OF THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM). (23rd June 2022) Authors: Macro, M.; Touzeau, C.; Mariette, C.; Manier, S.; Brechignac, S.; Vincent, L.; Hebraud, B.; Decaux, O.; Schulmann, S.; Lenoir, C.; Godmer, P.; Farge, A.; Peyro Saint Paul, L.; Parienti, J.-J.; Leleu, X. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗